Mitochondria, Manganese Superoxide Dismutase, and Cancer

Antioxidants and Redox Signaling

Volumn 6, Issue 3, 2004, Pages 483-487

  Oberley, Terry D ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CELL NUCLEUS DNA; FUMARATE HYDRATASE; GROWTH FACTOR; MANGANESE SUPEROXIDE DISMUTASE; MITOCHONDRIAL DNA; MITOCHONDRIAL PROTEIN; PEROXIDE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; REACTIVE OXYGEN METABOLITE; SUCCINATE DEHYDROGENASE; SUPEROXIDE; TRANSCRIPTION FACTOR; TRANSFER RNA;

CANCER; CANCER INHIBITION; CARCINOGENESIS; CELL DEATH; CELL FUNCTION; CELL HYPOXIA; CELL KINETICS; CITRIC ACID CYCLE; CYTOSOL; EDITORIAL; ENZYME ACTIVITY; GENE DELETION; GENE INSERTION; GENE MUTATION; HUMAN; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; NONHUMAN; OXIDATION REDUCTION REACTION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTON TRANSPORT; REOXYGENATION; RESPIRATORY CHAIN;

INSERTION SEQUENCES;

EID: 2442600197     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/152308604773934242     Document Type: Editorial

References (33)

1. Constantini P, Jacotot E, Decausdin D, and Kroemer G. Mitochondrion as a novel target of anticancer chemotherapy. J Natl Cancer Inst 92: 1042-1053, 2000.
2. Cuezva JM, Krajewska M, Lopez de Heredia M, Krajewski S, Santamaria G, Kim H, Zapata JM, Marusawa H, Chamorro M, and Reed JC. The bioenergetic signature of cancer: a marker of tumor progression. Cancer Res 62: 6674-6681, 2002.
3. Eng C, Kiuru M, Fernandez MJ, and Aaltonen LA. A role for mitochondrial enzymes in inherited neoplasia and beyond. Nat Rev/Cancer 3: 193-201, 2003.
4. Fliss MS, Usadel H, Caballero OL, Wu L, Buta MR, Eleff SM, Jen J, and Sidransky D. Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science 287: 2017-2019, 2000.
5. Galli S, Labato MI, Bal de Kier Joffe E, Carreras MC, and Poderoso JJ. Decreased mitochondrial nitric oxide synthase activity and hydrogen peroxide relate persistent tumoral proliferation to embryonic behavior. Cancer Res 63: 6370-6377, 2003.
6. Ghadially FN. Ultrastructural Pathology of the Cell and Matrix, 4th edit. Boston, MA: Butterworth-Heinemann, 1997, pp. 300-303.
7. Guidot DM, Repine JE, Kitlowski AD, Flores SC, Nelson SK, Wright RM, and McCord JM. Mitochondrial respiration scavenges extramitochondrial superoxide anion via a nonenzymatic mechanism. J Clin Invest 96: 1131-1136, 1995.
8. Hirai F, Motoori S, Kakinuma S, Tomita K, Indo HP, Kato H, Yamaguchi T, Yen H-C, St. Clair DK, Nagano T, Ozawa T, Saisho H, and Majima HJ. Mitochondrial signal lacking manganese superoxide dismutase failed to prevent cell death by reoxygenation following hypoxia in a human pancreatic cancer cell line, KP4. Antioxid Redox Signal 6: 523-535, 2004.
9. Kelso GF, Porteous CM, Coulter CV, Hughes G, Porteous WK, Ledgerwood EC, Smith RAJ, and Murphy MP. Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties. J Biol Chem 276: 4588-4596, 2001.
10. th Annual Meeting of the Oxygen Society: Abstract no. 314, 2002.
11. Kim A, Zhong W, and Oberley TD. Reversible modulation of cell cycle kinetics in NIH/3T3 mouse fibroblasts by inducible overexpression of mitochondrial manganese superoxide dismutase. Antioxid Redox Signal, 6: 489-500, 2004.
12. Kroemer G. Mitochondrial control of apoptosis. Biochem Soc Symp 66: 1-15, 1999.
13. Li S, Yan T, Yang J-Q, and Oberley TD, Oberley LW. The role of cellular glutathione peroxidase redox regulation in the suppression of tumor cell growth by manganese superoxide dismutase. Cancer Res 60: 3927-3939, 2000.
14. Li Y, Huang T-T, Carlson EJ, Melov S, Ursell PC, Olson JL, Noble LJ, Yoshimura MP, Berger C, Chan PH, Wallace DC, and Epstein CJ. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat Genet 11: 376-381, 1995.
15. Mathupala SP, Rempel A, and Pedersen PL. Aberrant glycolytic metabolism of cancer cells: a remarkable coordination of genetic, transcriptional, post-translational, and mutational events that lead to a critical role for type II hexokinase. J Bioenerg Biomembr 29: 339-343, 1997.
16. McCord JM, Keele BB, and Fridovich I. An enzyme based theory of obligate anaerobiosis: the physiologic function of superoxide dismutase. Proc Natl Acad Sci U S A 68: 1024-1027, 1971.
17. Melov S, Schneider JA, Day BJ, Hinerfeld, Coskun P, Mirra SS, Crapo JD, and Wallace DC. A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase. Nat Genet 18: 159-163, 1998.
18. Melov S, Coskun P, Patel M, Tuinstra R, Cottrell B, Jun AS, Zastawny TH, Dizdaroglu M, Goodman SI, Huang T-T, Miziorko H, Epstein CJ, and Wallace DC. Mitochondrial disease in superoxide dismutase 2 mutant mice. Proc Natl Acad Sci U S A 96: 846-851, 1999.
19. Mitrunen K, Sillanpaa P, Kataja V, Eskelinen M, Kosma V-M, Benhamou S, Uusitupa M, and Hirvonen A. Association between manganese superoxide dismutase (MnSOD) gene polymorphism and breast cancer risk. Carcinogenesis 22: 827-829, 2001.
20. Nemoto S, Takeda K, Yu Z-X, Ferrans VJ, and Finkel T. Role for mitochondrial oxidants as regulators of cellular metabolism. Mol Cell Biol 20: 7311-7318, 2000.
21. Nulton-Persson AC and Szweda LI. Modulation of mitochondrial function by hydrogen peroxide. J Biol Chem 276: 23357-23361, 2001.
22. Oberley LW. Anticancer therapy by overexpression of superoxide dismutase. Antioxid Redox Signal 3: 461-472, 2001.
23. Oberley LW and Buettner GR. Role of superoxide dismutase in cancer: a review. Cancer Res 39: 1141-1149, 1979.
24. Oberley TD. Oxidative damage and cancer. Am J Pathol 160: 403-408, 2002.
25. Oberley TD, Zhong W, Szweda LI, and Oberley LW. Localization of antioxidant enzymes and oxidative damage products in normal and malignant prostate epithelium. Prostate 44: 144-155, 2000.
26. Oberley TD, Xue Y, Zhao Y, Kiningham K, Szweda LI, and St. Clair DK. In situ reduction of oxidative damage, increased cell turnover, and delay of mitochondrial injury by overexpression of manganese superoxide dismutase in a multistage skin carcinogenesis model. Antioxid Redox Signal 6:: 537-548, 2004.
27. Ridnour LA, Oberley TD, and Oberley LW. Tumor suppressive effects of MnSOD overexpression may involve imbalance in peroxide generation versus peroxide removal. Antioxid Redox Signal 6: 501-512, 2004.
28. 2. Free Radic Biol Med 29: 801-813, 2000.
29. Thress K, Kornbluth S, and Smith JJ. Mitochondria at the crossroad of apoptotic cell death. J Bioenerg Biomembr 31: 321-326, 1999.
30. Verma M, Kagan J, Sidransky D, and Srivastava S. Proteomic analysis of cancer-cell mitochondria. Nat Rev/Cancer 3: 789-795, 2003.
31. Zhao Y, Xue Y, Oberley TD, Kiningham KK, Lin S-M, Yen H-C, Majima H, Hines J, and St. Clair D. Overexpression of manganese superoxide dismutase suppresses tumor formation by modulation of activator protein-1 signaling in a multistage skin carcinogenesis model. Cancer Res 61: 6082-6088, 2001.
32. Zhao Y, Oberley TD, Chaiswing L, Lin S-M, Epstein CJ, Huang T-T, and St. Clair D. Manganese superoxide deficiency enhances cell turnover via tumor promoter-induced alterations in AP-1 and p53-mediated pathways in a skin cancer model. Oncogene 21: 3836-3846, 2002.
33. Zhong W, Yan T, Webber MM, and Oberley TD. Alteration of cellular phenotype and responses to oxidative stress by manganese superoxide dismutase and a superoxide dismutase mimic in RWPE-2 human prostate adenocarcinoma cells. Antioxid Redox Signal 6: 513-522, 2004.